Article
Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.
Transfusion - 1 Jan 2008
Modrof Jens, Berting Andreas, Tille Björn, Klotz Andreas, Forstner Christina, Rieger Sandra, Aberham Claudia, Gessner Matthias, Kreil Thomas R
Abstract excerpt
BACKGROUND: Human parvovirus B19 (B19V) is a highly prevalent pathogen, and plasma pools for manufacturing of plasma-derived products have been shown to contain antibodies against B19V (B19V immunoglobulin G [IgG]). STUDY DESIGN AND METHODS: The megakaryoblastic cell line UT7/Epo-S1 can be infected with B19V Genotype 1 and as demonstrated here by immunocytochemistry, Western blot, and reverse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
